about
Cytohesins are cytoplasmic ErbB receptor activatorsIntermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancerTransient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer.The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesisin lung cancer.Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.
P50
Q24303022-920876FB-9C00-431C-A283-68783375EBF3Q38673369-6C9785B1-DFA1-4B47-AD4A-939EC36AE851Q39011070-CB0CFC2A-ACB2-4E6F-A2AE-D90DD06F4B5DQ39062237-EEF018F5-EF9D-403D-8AE9-62F8AE8CEE83Q39186300-FB0F7D7F-2D95-4D59-B2EE-60563CAE476AQ46124717-C0F1509B-9AE1-4EA8-9D35-11517D5563A4Q52301110-B6E3344F-34C3-4594-9A3C-1DA27A600F27
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sampurna Chatterjee
@ast
Sampurna Chatterjee
@en
Sampurna Chatterjee
@es
Sampurna Chatterjee
@nl
Sampurna Chatterjee
@sl
সম্পূর্ণা চ্যাটার্জি
@bn
type
label
Sampurna Chatterjee
@ast
Sampurna Chatterjee
@en
Sampurna Chatterjee
@es
Sampurna Chatterjee
@nl
Sampurna Chatterjee
@sl
সম্পূর্ণা চ্যাটার্জি
@bn
prefLabel
Sampurna Chatterjee
@ast
Sampurna Chatterjee
@en
Sampurna Chatterjee
@es
Sampurna Chatterjee
@nl
Sampurna Chatterjee
@sl
সম্পূর্ণা চ্যাটার্জি
@bn
P106
P31
P496
0000-0003-0850-0328